IGKV2D-24 and chronic obstructive pulmonary disease: A recent study revealed that α7 nAChR acts via an activation of adenylyl cyclase 6 and a lipid raft-mediated endocytosis of TLR4 in a COPD mouse model and proposed the use of α7 agonists as a novel approach for COPD treatment [45].